{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-040875","form_type":"8-K","ticker":"ADTX","cik":"0001726711","company_name":"Aditxt, Inc.","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.764429+00:00","generated_at":"2026-06-02T11:51:44.766897+00:00","sec_items":["1.01","5.03","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aditxt raises $4.2M in private placement of convertible preferred and warrants","bullets":["Gross proceeds $4.2M from sale of 4,186 Series C-1 convertible preferred shares, 4,186 Series D-1 voting preferred shares, and warrants for ~1.6M common shares.","Series C-1 convertible at $2.595/share; warrants exercisable at $2.47/share for 5 years, beginning 6 months after issuance.","Company to use $1.0M of net proceeds for merger obligations with Evofem Biosciences; remainder for working capital.","Placement agent Dawson James receives 7% cash fee and warrants for 5% of securities sold.","Private placement expected to close on or about May 6, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-040875","json":"https://secwatch.observer/filing/0001213900-24-040875.json","markdown":"https://secwatch.observer/filing/0001213900-24-040875.md","text":"https://secwatch.observer/filing/0001213900-24-040875.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024040875/0001213900-24-040875-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024040875/ea0205527-8k_aditxt.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T11:51:44.766897+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7c2f1038f8d365fc798da40ea5286be518ec2083","claim":"Aditxt, Inc.: On May 2, 2024, the Company filed Certificates of Designation for Series C-1 and Series D-1 Preferred Stock with the Secretary of State of Delaware, establishing the terms of these new preferred stock series (effective 2024-05-02).","evidence_excerpt":"On May 2, 2024, the Company filed a Certificate of Designation for its Series C-1 Preferred Stock with the Secretary of State of Delaware (the “ Series C-1 Certificate of Designations ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024040875/0001213900-24-040875-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-05-02"}],"fact_type":"governance_change"},{"claim_id":"4a396fc53fffd5ce6e4429f6c68e74399926698f","claim":"Aditxt, Inc. entered into Securities Purchase Agreement with certain accredited investors (effective 2024-05-02).","evidence_excerpt":"On May 2, 2024, Aditxt, Inc. (the \" Company \") entered into a Securities Purchase Agreement (the \" Purchase Agreement \") with certain accredited investors","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390024040875/0001213900-24-040875-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Effective","value":"2024-05-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}